Wegovy weight loss journeys on TikTok: what the scale hides

What did @themodlittlemelanin actually say?

The creator says they started a weight loss journey in November 2022 and, two years later, had lost 125 pounds. That's the whole claim. No specific drug dose mentioned, no medical advice given, just a personal milestone shared with visible pride. To their credit, they called it "literally insane," which is actually a reasonable reaction to losing that much weight in that timeframe.

The hashtag wegovyweightloss tells us the method: semaglutide (Wegovy), the GLP-1 receptor agonist approved by the FDA for chronic weight management in adults with obesity or overweight with a weight-related condition. So we're fact-checking a personal result tied to a real, regulated medication, not some detox tea or appetite suppressant gummy.

Does the science back this up?

A 125-pound loss over two years is on the high end of what clinical trials show, but it is not impossible, especially for someone starting at a higher body weight. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) found participants lost an average of 14.9% of body weight over 68 weeks on semaglutide 2.4 mg weekly. That average, though, masks a wide range of individual outcomes.

More relevant: the STEP 5 trial (Garvey et al., 2022, Nature Medicine) followed participants for two years and found sustained weight loss of around 15.2% on average, with some individuals exceeding 20%. For a person starting at, say, 350 pounds, a 20% loss gets you to 70 pounds. To hit 125 pounds lost, you would need to start considerably heavier, sustain the medication for the full period, and likely combine it with meaningful lifestyle changes.

• Average semaglutide weight loss at 2 years: roughly 15% of starting body weight
• Top-quartile responders in trials exceed 20% loss
• Lifestyle intervention on top of medication consistently improves outcomes

What did they get wrong (or right)?

Honestly? There is not much to fact-check here in a negative sense. The creator did not make a mechanistic claim, did not name a dose, did not say Wegovy will do this for everyone. They shared a personal result. That is a meaningful distinction.

The one thing worth flagging: a result like this, shared to 41,800 viewers, can set an implicit expectation that 125 pounds in two years is a standard outcome. It is not. It is an exceptional outcome. The FDA-approved label for Wegovy notes that roughly 1 in 3 participants in the STEP 1 trial lost less than 5% of body weight. So while the creator's result is plausible and worth celebrating, the audience needs to understand that individual responses to semaglutide vary significantly, and many people on GLP-1 medications lose a fraction of what this creator lost.

No misinformation here. Just context the video cannot provide in a few seconds of footage.

What should you actually know?

GLP-1 receptor agonists like semaglutide work by mimicking a gut hormone that signals satiety, slows gastric emptying, and reduces appetite. They are not magic. Response rates differ based on genetics, starting weight, adherence, diet, physical activity, and how long you stay on the medication.

The Davies et al. 2021 review in Diabetes Care confirmed that discontinuing semaglutide leads to weight regain in most patients, with about two-thirds of lost weight returning within a year of stopping. This is not a failure of willpower. It reflects the chronic nature of obesity as a metabolic condition.

If you are watching this video and wondering whether Wegovy could work for you, that is a conversation to have with a licensed provider who can review your health history. A TikTok transformation, however genuine, is not a treatment plan.